The retinal pathology seen here of AQP4 loss with increased GFAP and with minimal early complement deposition corresponds to the pathology seen in active human NMO lesions found in the brain and spinal cord classified as type 4 pathology [30]. Here, AQP4 is linked to neuromyelitis optica.